Trisubstituted triazines having the formula:

##STR00001##

wherein: X is O and n is 0 or 1, Y is OH, NH.sub.2 or CH.sub.2NH.sub.2, Q is P, PO, CH or N, when Q is P, R is phenyl, when Q is PO, Z is R or OR, and R is alkyl or phenyl, when Q is CH, Z is PO(R).sub.2 or PO(OR).sub.2, when Q is N, Z is R, and their uses as epoxy and cyclic carbonate polymer curing agents.

Trisubstituted triazines having the formula:

##STR00001##

wherein: X is O and n is 0 or 1, Y is OH, NH.sub.2 or CH.sub.2NH.sub.2, Q is P, PO, CH or N, when Q is P, R is phenyl, when Q is PO, Z is R or OR, and R is alkyl or phenyl, when Q is CH, Z is PO(R).sub.2 or PO(OR).sub.2, when Q is N, Z is R, and their uses as epoxy and cyclic carbonate polymer curing agents.

Disclosed are compounds represented by structural formula

##STR00001## methods of producing compounds represented by structural formula, and their use in inhibiting oxidation in an oxidizable material.

Disclosed are compounds represented by structural formula

##STR00001## methods of producing compounds represented by structural formula, and their use in inhibiting oxidation in an oxidizable material.

A process for preparing a triazine-based precursor for producing a micro-particulate complex containing a far infrared-emissive silica particle comprises steps of: a) subjecting 2-4-6-trichloro-1,3,5-triazine and a first nucleophilic compound to a displacement reaction in the presence of a first solvent at a first temperature range to form an intermediate; and b) subjecting the intermediate and a second nucleophilic compound to a further displacement reaction in the presence of a second solvent at a second temperature range higher than the first temperature range.

A process for preparing a triazine-based precursor for producing a micro-particulate complex containing a far infrared-emissive silica particle comprises steps of: a) subjecting 2-4-6-trichloro-1,3,5-triazine and a first nucleophilic compound to a displacement reaction in the presence of a first solvent at a first temperature range to form an intermediate; and b) subjecting the intermediate and a second nucleophilic compound to a further displacement reaction in the presence of a second solvent at a second temperature range higher than the first temperature range.

Provided are a nonaqueous electrolyte capable of providing a nonaqueous electrolyte energy storage device with reduced direct current resistance and an increased capacity retention ratio after charge-discharge cycles, a nonaqueous electrolyte energy storage device including such a nonaqueous electrolyte, and a method for producing such a nonaqueous electrolyte energy storage device. One mode of the present invention is a nonaqueous electrolyte for an energy storage device, containing an additive represented by the following Formula (1) or Formula (2). In Formula (1), R.sup.1 to R.sup.4 are each independently a hydrogen atom or a group represented by NR, ORa, SRa, etc., with the proviso that at least one of R.sup.1 to R.sup.4 is a group represented by ORa, SRa, COORa, CORa, SO2Ra, or SO3Ra. In Formula (2), R.sup.5 to R.sup.7 are each independently a hydrogen atom or a group represented by NRb.sup.2, OR.sup.b, or SR.sup.b, with the proviso that at least one of R.sup.5 to R.sup.7 is a group represented by SRb.

##STR00001##

Provided are a nonaqueous electrolyte capable of providing a nonaqueous electrolyte energy storage device with reduced direct current resistance and an increased capacity retention ratio after charge-discharge cycles, a nonaqueous electrolyte energy storage device including such a nonaqueous electrolyte, and a method for producing such a nonaqueous electrolyte energy storage device. One mode of the present invention is a nonaqueous electrolyte for an energy storage device, containing an additive represented by the following Formula (1) or Formula (2). In Formula (1), R.sup.1 to R.sup.4 are each independently a hydrogen atom or a group represented by NR, ORa, SRa, etc., with the proviso that at least one of R.sup.1 to R.sup.4 is a group represented by ORa, SRa, COORa, CORa, SO2Ra, or SO3Ra. In Formula (2), R.sup.5 to R.sup.7 are each independently a hydrogen atom or a group represented by NRb.sup.2, OR.sup.b, or SR.sup.b, with the proviso that at least one of R.sup.5 to R.sup.7 is a group represented by SRb.

##STR00001##

Provided are a triazine dione derivative, a preparation method therefor and an application thereof in medicine. Specifically, provided are a triazine dione derivative represented by general formula (I), a preparation method therefor, a pharmaceutical composition containing the derivative and a use thereof as a therapeutic agent, particularly a use in preparing a myosin inhibitor and a use in preparing a drug for treating hypertrophic cardiomyopathy (HCM) or heart diseases having pathophysiological features related to HCM.

##STR00001##

Provided are a triazine dione derivative, a preparation method therefor and an application thereof in medicine. Specifically, provided are a triazine dione derivative represented by general formula (I), a preparation method therefor, a pharmaceutical composition containing the derivative and a use thereof as a therapeutic agent, particularly a use in preparing a myosin inhibitor and a use in preparing a drug for treating hypertrophic cardiomyopathy (HCM) or heart diseases having pathophysiological features related to HCM.

##STR00001##